Toyocamycin
Chemical Name: 4-Amino-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
Purity: ≥98%
Biological Activity
Toyocamycin is an adenosine analog; antifungal antibiotic. Inhibits RNA self-cleavage in HEK79 cells and PI 3-kinase activity in A431 epidermoid carcinoma cell membrane fractions. Also inhibits thapsigargin-induced XBP1-luciferase activation and induces apoptosis in multiple myeloma cell lines.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.
Ri et al.
Blood.Cancer.J., 2012;2:e79 -
Inhibition of phosphatidylinositol kinase by toyocamycin.
Nishioka et al.
J.Antibiot. (Tokyo)., 1990;43:1586 -
Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.
Yen et al.
RNA, 2006;12:797
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for Toyocamycin
The citations listed below are publications that use Tocris products. Selected citations for Toyocamycin include:
1 Citation: Showing 1 - 1
-
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Authors: Tanabe Et al.
Oncotarget 2018;9:14428
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Toyocamycin
There are currently no reviews for this product. Be the first to review Toyocamycin and earn rewards!
Have you used Toyocamycin?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
